DE602005005999D1 - Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörpern - Google Patents

Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörpern

Info

Publication number
DE602005005999D1
DE602005005999D1 DE602005005999T DE602005005999T DE602005005999D1 DE 602005005999 D1 DE602005005999 D1 DE 602005005999D1 DE 602005005999 T DE602005005999 T DE 602005005999T DE 602005005999 T DE602005005999 T DE 602005005999T DE 602005005999 D1 DE602005005999 D1 DE 602005005999D1
Authority
DE
Germany
Prior art keywords
hiv
peptides
detecting anti
modified
synthetic peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005005999T
Other languages
English (en)
Other versions
DE602005005999T2 (de
Inventor
Stephane Gadelle
Francois Rieunier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Innovations SAS
Original Assignee
Bio Rad Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur SA filed Critical Bio Rad Pasteur SA
Publication of DE602005005999D1 publication Critical patent/DE602005005999D1/de
Application granted granted Critical
Publication of DE602005005999T2 publication Critical patent/DE602005005999T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
DE602005005999T 2004-08-06 2005-07-27 Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörper Active DE602005005999T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0408733 2004-08-06
FR0408733A FR2874017B1 (fr) 2004-08-06 2004-08-06 Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
PCT/FR2005/001969 WO2006024752A1 (fr) 2004-08-06 2005-07-27 Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih

Publications (2)

Publication Number Publication Date
DE602005005999D1 true DE602005005999D1 (de) 2008-05-21
DE602005005999T2 DE602005005999T2 (de) 2009-07-23

Family

ID=34948256

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005005999T Active DE602005005999T2 (de) 2004-08-06 2005-07-27 Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörper

Country Status (11)

Country Link
US (1) US7988975B2 (de)
EP (1) EP1778721B1 (de)
JP (1) JP4476327B2 (de)
CN (1) CN101035804B (de)
AT (1) ATE391721T1 (de)
CA (1) CA2576715C (de)
DE (1) DE602005005999T2 (de)
ES (1) ES2302236T3 (de)
FR (1) FR2874017B1 (de)
RU (1) RU2352579C2 (de)
WO (1) WO2006024752A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471692A (en) * 2009-07-08 2011-01-12 Complix Nv HIV gp41-binding single-chain coiled-coil peptide comprising heptad repeats
TWI746473B (zh) 2015-11-02 2021-11-21 美商辛分子醫藥有限公司 針對細胞內抗原之單域抗體

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
CZ300927B6 (cs) 1997-04-09 2009-09-16 Bio-Rad Pasteur Syntetický peptid monomerního typu, prostredek, který ho obsahuje, zpusob imunologické in vitro kvantifikace a diagnostický kit pro použití v biologických testech pro identifikaci infekcí zpusobených viry HIV
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux

Also Published As

Publication number Publication date
ES2302236T3 (es) 2008-07-01
EP1778721B1 (de) 2008-04-09
WO2006024752A1 (fr) 2006-03-09
CA2576715A1 (fr) 2006-03-09
JP4476327B2 (ja) 2010-06-09
FR2874017B1 (fr) 2006-11-24
EP1778721A1 (de) 2007-05-02
DE602005005999T2 (de) 2009-07-23
JP2008509112A (ja) 2008-03-27
ATE391721T1 (de) 2008-04-15
US20090263785A1 (en) 2009-10-22
CN101035804A (zh) 2007-09-12
RU2352579C2 (ru) 2009-04-20
US7988975B2 (en) 2011-08-02
FR2874017A1 (fr) 2006-02-10
CA2576715C (fr) 2012-01-03
CN101035804B (zh) 2013-04-10
RU2007108306A (ru) 2008-09-20

Similar Documents

Publication Publication Date Title
EA200300336A1 (ru) Пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
TW200512457A (en) Method of diagnosing SARS corona virus infection
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
GB2438802A (en) Structure of the hepatitis C virus NS5A protein
CY1116632T1 (el) Εξουδετερωτες αντισωματων του τελεστη διεγερσης αποικιων κοκκιοκυτταρων μακροφαγων ανθρωπου
PL367679A1 (en) A soluble complex comprising a retroviral surface glycoprotein
DE50214416D1 (de) Vermehrung von viren in zellkultur
RS52769B (sr) Kompozicije i postupci za povećanje mineralizacije kostiju
WO2004084805A3 (en) Acetylated tat polypeptides and methods of use thereof
RS54133B1 (en) ANTI-IL-6 ANTIBODIES, PREPARATIONS, PREPARATION AND USE PROCEDURES
ATE414106T1 (de) Pegylierte single-domain-antikörper (dab)
ATE489623T1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
WO2007005948A3 (en) Methods and compositions for diagnosis and treatment of viral and bacterial infections
EA200300335A1 (ru) Регуляторные и вспомогательные пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
ATE391721T1 (de) Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörpern
DE60221805D1 (de) Peptide mit affinität zu gp120, und ihre verwendungen
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
TW200513260A (en) Hepatitis C virus derived peptides
WO2003060098A3 (en) Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna
WO2010121013A3 (en) Molecularly imprinted polymers for detecting hiv-1
EP1791556A4 (de) Modifizierte hiv-1-hüllproteine
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
FR2815634B1 (fr) Anticorps monoclonaux diriges contre des virus de l'hepatite b
TR199902757T2 (xx) Grup O HIV-1 vir�slerine ba�l� enfeksiyonlar�n tespiti i�in biyolojik testlerde kullan�labilen sentetik peptitler.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition